Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) rose 4.3% on Thursday . The company traded as high as $18.43 and last traded at $18.46. Approximately 16,741 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 25,053 shares. The stock had previously closed at $17.70.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. UBS Group increased their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a report on Monday, January 27th. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a report on Tuesday, November 19th.
Read Our Latest Research Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
The company's fifty day moving average is $17.28.
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Read More
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
